Latest News

A new multi-institutional study has found there was a dramatic decline in thyroid cancer diagnoses during the COVID-19 pandemic, raising concerns about a potential wave of more advanced cancer cases in the future.

Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market. However, recent years have seen a number of high-profile market withdrawals and failed confirmatory trials.

XEC is on track to become the new dominant COVID-19 strain this winter. Yale and New Haven experts weigh in on why you should still get the new vaccine even though it may be less effective at neutralization because it is a recombinant variant.

A new study from the Yale School of Public Health (YSPH) offers fresh insights into our understanding of colorectal cancer (CRC) that challenge the conventional right-sided and left-sided classifications of the disease.

Two distinguished Yale professors, Dr. Hongyu Zhao, PhD, and Dr. Mark Gerstein, PhD, have been awarded a $1.9 million grant from the National Human Genome Research Institute (NHGRI) to advance the Developmental Genotype-Tissue Expression (dGTEx) project. This landmark initiative aims to unravel the complexities of gene expression patterns across developmental stages, providing critical insights into genetic influences on health and disease.

A new study finds that dozens of countries have not met their commitments to a 2021 international program of health care sustainability measures.

Yale Center on Climate Change and Health tackle the challenges of urban health, children’s health, and health care sustainability at Climate Week NYC

It’s been one year since the Hamas attacks on Israel. The ensuing war has led to a humanitarian crisis in Gaza, leaving many civilians without access to food, shelter, and medicine. This hour, we get an update on humanitarian aid in the region.

On October 6, 2024, Dr. Cary Gross spoke with Dr. Eric Winer on Yale Cancer Answers.